Cansu Benli Işık
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cansu Benli Işık has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Hatice Ölger Uzuner
Training and Research Hospital, Department of Pathology, Samsun, Turkey
2 shared publications - Saime Gül Barut
Istanbul Haseki Eğitim ve Araştırma Hastanesi
2 shared publications - Ahmet Sarac
Department of Pediatric Surgery, Mogadishu Somalia Turkey Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Somalia; Department of Pediatric Surgery, Samsun Training and Research Hospital, Turkey
1 shared publication - Ali Mızrak
İstanbul Haseki Eğitim Araştırma Hastanesi
1 shared publication - Ayşe Gökçen Sade
Sultan Abdulhamid Han Educational and Research Hospital, Türkiye
1 shared publication - Begüm Çalım Gürbüz
Pathology Department, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey
1 shared publication
Latest Publications
- 30 September 2025
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 15 (3) , 531-537
The Effects of Immunocytochemistry on Diagnostic Accuracy in Thyroid Fine Needle Aspiration Cytology: A Retrospective Study
Objective: In thyroid cytology, ancillary studies are often utilized for intermediate-category cases to better differentiate between benign and malignant lesion. For this purpose, immunocytochemical markers may be preferred because they are cheaper than molecular studies and can be applied in many laboratories. This study retrospectively compares the diagnostic accuracy of cytology samples with and without immunocytochemistry and calculates the frequency of immunocytochemical marker use, as well as sensitivity and specificity rates. Methods: Between 2015 and 2023, 1816 samples from 1506 patients with a histological diagnosis after cytological examination (thyroidectomy-lobectomy) were included. Cases without a histological diagnosis were excluded. The Thin Prep® method was used for all cytological sample preparations, and cell blocks were obtained. Demographic information, Bethesda system categories, immunocytochemical markers used, and histological diagnoses were recorded. Cases using at least one immunocytochemical marker were re-evaluated, and staining results were categorized as positive, focally positive, or negative. SPSS 15® software was used to assess data normality and perform statistical analyses. Results: The most frequently used markers were HBME-1 (n=167), CK 19 (n=106), Galectin-3 (n=75), and CD 56 (n=6). Sensitivity rates for HBME-1, CK 19, Galectin-3, and CD 56 were 91%, 94%, 76%, and 75%, respectively; specificity rates were 63%, 61%, 80%, and 50%, respectively. Comparing groups with and without immunocytochemistry, the risk of malignancy was: 6.95%-6.97% for Bethesda category II; 21.7%-19.0% for Bethesda category III; 76.0%-37.1% for Bethesda category IV; 94.0%-95.0% for category V; and 100% for category VI. Conclusion: In the follicular neoplasm group (Bethesda category IV) the risk of malignancy was higher in the immunohistochemistry applied group. No significant difference in malignancy risk was observed between groups with and without immunocytochemistry in other categories. Considering that immunocytochemical markers were predominantly applied in diagnostically challenging Bethesda categories, the similar malignancy risks across groups may suggest immunocytochemistry aids in accurate categorization. However, according to the results of this study, routine use of immunohistochemical markers in thyroid cytology is unnecessary except for Bethesda category IV.
- 30 September 2025
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 15 (3) , 531-537
The Effects of Immunocytochemistry on Diagnostic Accuracy in Thyroid Fine Needle Aspiration Cytology: A Retrospective Study
Objective: In thyroid cytology, ancillary studies are often utilized for intermediate-category cases to better differentiate between benign and malignant lesion. For this purpose, immunocytochemical markers may be preferred because they are cheaper than molecular studies and can be applied in many laboratories. This study retrospectively compares the diagnostic accuracy of cytology samples with and without immunocytochemistry and calculates the frequency of immunocytochemical marker use, as well as sensitivity and specificity rates. Methods: Between 2015 and 2023, 1816 samples from 1506 patients with a histological diagnosis after cytological examination (thyroidectomy-lobectomy) were included. Cases without a histological diagnosis were excluded. The Thin Prep® method was used for all cytological sample preparations, and cell blocks were obtained. Demographic information, Bethesda system categories, immunocytochemical markers used, and histological diagnoses were recorded. Cases using at least one immunocytochemical marker were re-evaluated, and staining results were categorized as positive, focally positive, or negative. SPSS 15® software was used to assess data normality and perform statistical analyses. Results: The most frequently used markers were HBME-1 (n=167), CK 19 (n=106), Galectin-3 (n=75), and CD 56 (n=6). Sensitivity rates for HBME-1, CK 19, Galectin-3, and CD 56 were 91%, 94%, 76%, and 75%, respectively; specificity rates were 63%, 61%, 80%, and 50%, respectively. Comparing groups with and without immunocytochemistry, the risk of malignancy was: 6.95%-6.97% for Bethesda category II; 21.7%-19.0% for Bethesda category III; 76.0%-37.1% for Bethesda category IV; 94.0%-95.0% for category V; and 100% for category VI. Conclusion: In the follicular neoplasm group (Bethesda category IV) the risk of malignancy was higher in the immunohistochemistry applied group. No significant difference in malignancy risk was observed between groups with and without immunocytochemistry in other categories. Considering that immunocytochemical markers were predominantly applied in diagnostically challenging Bethesda categories, the similar malignancy risks across groups may suggest immunocytochemistry aids in accurate categorization. However, according to the results of this study, routine use of immunohistochemical markers in thyroid cytology is unnecessary except for Bethesda category IV.
- 1 February 2024
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 12 (1) , 90-97
Our Five Years of Kaposi’s Sarcoma Experience: Which Histopathological Parameters are More Valuable in Diagnosis?
- 1 February 2024
- Published by Bezmialem Vakif University in Bezmialem Science
- Vol. 12 (1) , 90-97
Our Five Years of Kaposi’s Sarcoma Experience: Which Histopathological Parameters are More Valuable in Diagnosis?
- Open Access
- 15 October 2022
- Published by Academician Publishing
Deri Eki Tümörleri
Deri eki tümörleri nadir görülen ve birbirine benzeyen tümörler olduğundan tanılarının konması ve ayırıcı tanılarının yapılması genellikle zordur. Bu konuda ulaşılabilen Türkçe kaynakların da sınırlı olması nedeniyle bu kitabın oluşturulma sürecini başlattık. Amacımız , genç meslektaşlarımıza yönelik güncel bir kaynak oluşturmaya katkıda bulunmaktı. Kitabın oluşumunda tüm yazarlarımız ile birlikte uzun ve yorucu bir süreçte elimizden gelen çabayı göstermiş olmamıza rağmen; varsa eksikliklerimiz için affınıza sığınıyoruz. Pilar Kılıf Akantomu ve Dilate Por Nurtaç ASA SARIKAŞ Prolifere Pilar Tümör Hazal TAŞ SOLAK Trikilemmom Emel DAŞGIN BİTLİS Trikofoliküloma Meryem YÜVRÜK Trikoepitelyoma Tevhide Bilgen ÖZCAN Pilomatriksoma Fatma Gülçiçek AYRANCI Trikoblastom Begüm ÇALIM GÜRBÜZ Tuçe SÖYLEMEZ AKKURT Trikilemmal Karsinom Dilek YILMAZ Sebase Hiperplazi Cansu BENLİ IŞIK Sebase Adenom Cemile ÖZDEMİR Sebaseoma Ezgi HACIHASANOĞLU Nevüs Sebaseus Vildan ELİBOL Sebasöz Karsinom Begüm ÇALIM GÜRBÜZ Hidrokistoma ve Kistadenom Gamze KULDUK Özben YALÇIN Silindirom Rabia Burçin GİRGİN Spiradenom Nilsen YILDIRIM ERDOĞAN Spiradenomdan Kaynaklanan Malign Neoplazi/Malign Spiradenom Nilsen YILDIRIM ERDOĞAN Siringom Rabia Burçin GİRGİN Siringofibroadenom Rabia Burçin GİRGİN Siringokistadenoma Papilliferum Nilüfer GÜRSAN Kondroid Siringom Meryem YÜVRÜK Hidradenom Gamze KULDUK Tübüler Apokrin Adenom Selma ERDOĞAN DÜZCÜ Papiller Ekrin Adenom Selma ERDOĞAN DÜZCÜ Poroma Özben YALÇIN Dermal Duktus Tümörü Zeynep Betül ERDEM Hidradenoma Papilliferum Nilüfer GÜRSAN Mikrokistik Adneksiyal Karsinom Ayşe Gökçen SADE Primer Kutanöz Adenoid Kistik Karsinom Zeynep TOSUNER Porokarsinom Zeynep TOSUNER Kutanöz Apokrin Karsinom Vildan ELİBOL Primer Kutanöz Müsinöz Karsinom Zeynep TOSUNER Emel DİKİCİOĞLU ÇETİN Hidradenokarsinom Melin ÖZGÜN GEÇER Digital Papiller Adenokarsinom Melin ÖZGÜN GEÇER
- 15 October 2022
- Published by Academician Publishing
Open AccessDeri Eki Tümörleri
Deri eki tümörleri nadir görülen ve birbirine benzeyen tümörler olduğundan tanılarının konması ve ayırıcı tanılarının yapılması genellikle zordur. Bu konuda ulaşılabilen Türkçe kaynakların da sınırlı olması nedeniyle bu kitabın oluşturulma sürecini başlattık. Amacımız , genç meslektaşlarımıza yönelik güncel bir kaynak oluşturmaya katkıda bulunmaktı. Kitabın oluşumunda tüm yazarlarımız ile birlikte uzun ve yorucu bir süreçte elimizden gelen çabayı göstermiş olmamıza rağmen; varsa eksikliklerimiz için affınıza sığınıyoruz. Pilar Kılıf Akantomu ve Dilate Por Nurtaç ASA SARIKAŞ Prolifere Pilar Tümör Hazal TAŞ SOLAK Trikilemmom Emel DAŞGIN BİTLİS Trikofoliküloma Meryem YÜVRÜK Trikoepitelyoma Tevhide Bilgen ÖZCAN Pilomatriksoma Fatma Gülçiçek AYRANCI Trikoblastom Begüm ÇALIM GÜRBÜZ Tuçe SÖYLEMEZ AKKURT Trikilemmal Karsinom Dilek YILMAZ Sebase Hiperplazi Cansu BENLİ IŞIK Sebase Adenom Cemile ÖZDEMİR Sebaseoma Ezgi HACIHASANOĞLU Nevüs Sebaseus Vildan ELİBOL Sebasöz Karsinom Begüm ÇALIM GÜRBÜZ Hidrokistoma ve Kistadenom Gamze KULDUK Özben YALÇIN Silindirom Rabia Burçin GİRGİN Spiradenom Nilsen YILDIRIM ERDOĞAN Spiradenomdan Kaynaklanan Malign Neoplazi/Malign Spiradenom Nilsen YILDIRIM ERDOĞAN Siringom Rabia Burçin GİRGİN Siringofibroadenom Rabia Burçin GİRGİN Siringokistadenoma Papilliferum Nilüfer GÜRSAN Kondroid Siringom Meryem YÜVRÜK Hidradenom Gamze KULDUK Tübüler Apokrin Adenom Selma ERDOĞAN DÜZCÜ Papiller Ekrin Adenom Selma ERDOĞAN DÜZCÜ Poroma Özben YALÇIN Dermal Duktus Tümörü Zeynep Betül ERDEM Hidradenoma Papilliferum Nilüfer GÜRSAN Mikrokistik Adneksiyal Karsinom Ayşe Gökçen SADE Primer Kutanöz Adenoid Kistik Karsinom Zeynep TOSUNER Porokarsinom Zeynep TOSUNER Kutanöz Apokrin Karsinom Vildan ELİBOL Primer Kutanöz Müsinöz Karsinom Zeynep TOSUNER Emel DİKİCİOĞLU ÇETİN Hidradenokarsinom Melin ÖZGÜN GEÇER Digital Papiller Adenokarsinom Melin ÖZGÜN GEÇER
- Open Access
- 30 August 2021
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 23 (2) , 228-231
Inflammatory Rectal Polyp with Osseous Metaplasia: Is It a Distinctive Disease Entity?
Osseous metaplasia is a heterotopic bone formation and it is encountered rarely in the gastrointestinal tract, especially in benign lesions. Although its pathophysiology is not known clearly, there are several theories suggested. In this case report, we presented a case of bone formation in a rectal inflammatory polyp presenting with rectal bleeding in a 7-year-old girl. Therewithal, we reviewed the literature and summarized the subject of osseous metaplasia in colon polyps. We detected some similarities in the cases presented that suggest it might be a distinctive disease entity. Osseous metaplasia in colorectal polyps is extremely rare. To our knowledge, this is the eleventh reported case of osseous metaplasia in a rectal inflammatory polyp. Although osseous metaplasia in colon polyps has not a significant effect on both clinic and the prognosis, it can be confusing when encountered in microscopic examination.
- 30 August 2021
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 23 (2) , 228-231
Open AccessInflammatory Rectal Polyp with Osseous Metaplasia: Is It a Distinctive Disease Entity?
Osseous metaplasia is a heterotopic bone formation and it is encountered rarely in the gastrointestinal tract, especially in benign lesions. Although its pathophysiology is not known clearly, there are several theories suggested. In this case report, we presented a case of bone formation in a rectal inflammatory polyp presenting with rectal bleeding in a 7-year-old girl. Therewithal, we reviewed the literature and summarized the subject of osseous metaplasia in colon polyps. We detected some similarities in the cases presented that suggest it might be a distinctive disease entity. Osseous metaplasia in colorectal polyps is extremely rare. To our knowledge, this is the eleventh reported case of osseous metaplasia in a rectal inflammatory polyp. Although osseous metaplasia in colon polyps has not a significant effect on both clinic and the prognosis, it can be confusing when encountered in microscopic examination.
- 19 May 2020
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 21 (3) , 207-212
Evaluation of the Prevalence of HER-2 Expression and Its Relationship with Prognostic Parameters in Colorectal Carcinoma
- 19 May 2020
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 21 (3) , 207-212
Evaluation of the Prevalence of HER-2 Expression and Its Relationship with Prognostic Parameters in Colorectal Carcinoma